berberine has been researched along with ex 527 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Du, H; Lin, Y; Lu, N; Sheng, M; Weng, Y; Xu, R; Yu, W | 1 |
| Shan, Y; Shang, W; Wu, Y; Xu, C; Yan, J; Yu, X; Zhang, H; Zhao, J | 1 |
2 other study(ies) available for berberine and ex 527
| Article | Year |
|---|---|
Berberine protects against ischemia/reperfusion injury after orthotopic liver transplantation via activating Sirt1/FoxO3α induced autophagy.
Topics: Animals; Apoptosis; Autophagy; Berberine; Carbazoles; Forkhead Box Protein O3; Liver; Liver Transplantation; Male; Protective Agents; Rats; Rats, Wistar; Reperfusion Injury; Sirtuin 1 | 2017 |
Berberine suppresses LPS-induced inflammation through modulating Sirt1/NF-κB signaling pathway in RAW264.7 cells.
Topics: Animals; Berberine; Carbazoles; Chemokine CCL2; Inflammation; Interleukin-6; Lipopolysaccharides; Macrophages; Mice; RAW 264.7 Cells; RNA, Small Interfering; Signal Transduction; Sirtuin 1; Transcription Factor RelA; Tumor Necrosis Factor-alpha | 2017 |